SEC Filings | Jasper Therapeutics, Inc

Filing date	Description	Form	Filing Group	View
October 25, 2019	CORRESP	CORRESP	Other	0001213900-19-021150.pdf 0001213900-19-021150.rtf 0001213900-19-021150.xls View HTML
November 14, 2019	CORRESP	CORRESP	Other	0001213900-19-023588.pdf 0001213900-19-023588.rtf 0001213900-19-023588.xls View HTML
October 22, 2021	CORRESP	CORRESP	Other	0001213900-21-054174.pdf 0001213900-21-054174.rtf 0001213900-21-054174.xls View HTML
October 14, 2022	CORRESP	CORRESP	Other	0001213900-22-064076.pdf 0001213900-22-064076.rtf 0001213900-22-064076.xls View HTML
May 3, 2023	CORRESP	CORRESP	Other	0001213900-23-036051.pdf 0001213900-23-036051.rtf 0001213900-23-036051.xls View HTML
April 21, 2023	An annual report to security holders	ARS	Annual Filings	0001213900-23-031678.pdf 0001213900-23-031678.rtf View HTML
April 22, 2024	An annual report to security holders	ARS	Annual Filings	0001213900-24-034840.pdf 0001213900-24-034840.rtf View HTML
September 29, 2021	Amendment to a previously filed 8-K	8-K/A	Current Reports	0001213900-21-050602.pdf 0001213900-21-050602.rtf 0001213900-21-050602.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 25, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	0001213900-19-024606.pdf 0001213900-19-024606.rtf 0001213900-19-024606.xls View HTML
November 27, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	0001213900-19-024928.pdf 0001213900-19-024928.rtf 0001213900-19-024928.xls View HTML

Data provided by Kaleidoscope.